SCHEMBL22766735

SCHEMBL22766735

C=C/C=C\c1oc2ccc(-c3ccc(-c4c5ccccc5c(-c5cccc6ccccc56)c5ccccc45)cc3)cc2c1C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
CDK9 P50750 1/20 0.34
DYRK1A Q13627 1/20 0.34
DYRK2 Q92630 1/20 0.34
CA12 O43570 3/20 0.33
CA1 P00915 3/20 0.33
CA2 P00918 3/20 0.33
CA9 Q16790 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
DHFR P00374 1/20 0.32
ALDH1A1 P00352 2/20 0.32
HSD17B10 Q99714 2/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
RAB9A P51151 1/20 0.32
ATM Q13315 1/20 0.32
ENPP3 O14638 1/20 0.31
ENPP1 P22413 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23919327 0.93 MAOA (0.37) MAOAMAOBCDK9DYRK1ADYRK2
SCHEMBL22063087 0.92 MAOA (0.38) MAOAMAOBCDK9DYRK1ADYRK2
SCHEMBL25120189 0.91 HSP90AA1 (0.32) MAOAMAOB
SCHEMBL24117556 0.90 MAOA (0.36) MAOAMAOBCDK9DYRK1ADYRK2
SCHEMBL22766711 0.88 PLA2G2A (0.34) MAOBCDK9DYRK1ADYRK2L3MBTL1
SCHEMBL22356518 0.88 PLA2G2A (0.38) CDK9DYRK1ADYRK2L3MBTL1ALDH1A1
SCHEMBL24813480 0.87 HSP90AA1 (0.30) CDK9DYRK1ADYRK2
SCHEMBL24718901 0.86 PLA2G2A (0.36) MAOBCDK9DYRK1ADYRK2L3MBTL1
SCHEMBL24961104 0.86 PLA2G2A (0.38) CDK9DYRK1ADYRK2L3MBTL1ALDH1A1
SCHEMBL22063393 0.86 L3MBTL1 (0.36) MAOBCDK9DYRK1ADYRK2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210395233-A1 NEW COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-12-23 US disclosed
US-20200388767-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2020-12-10 US disclosed
US-20160318847-A1 SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY ACADIA PHARMACEUTICALS INC. 2016-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395233-A1 NEW COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE AHR, UQCRB, AOC2 MAOA 331/4885MAOB 76/4885CDK9 455/4885
US-20160318847-A1 SUBSTITUTED PHENETHYLAMINES WITH SEROTONINERGIC AND/OR NOREPINEPHRINERGIC ACTIVITY SLC6A4, HTR4, GPR34 MAOA 193/4885MAOB 134/4885CDK9 1408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.